Stepwise Screening for Silent Atrial Fibrillation After Stroke

CompletedOBSERVATIONAL

Enrollment

264

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

March 23, 2023

Study Completion Date

March 23, 2023

Conditions

Ischemic Cerebrovascular Accident

Interventions

BIOLOGICAL

Blood sample

2 ml of blood for testing for serum biomarkers (IL-6, GDF-15, soluble ST-2 soluble, osteoprotegerin, galectin 3)

PROCEDURE

Long term ECG monitor

Fitting and removal of a long term ECG monitor (SpiderFlash, LivaNova)

PROCEDURE

Monitoring ECG

Recording of automatic ECG monitor results (CSM Philips IntelliVue MP50 system)

Trial Locations (1)

CHU Dijon Bourgogne, Dijon

All Listed Sponsors

lead

Centre Hospitalier Universitaire Dijon

OTHER

NCT03570060 - Stepwise Screening for Silent Atrial Fibrillation After Stroke | Biotech Hunter | Biotech Hunter